Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Discover which travel rewards credit cards come with no fees. Enjoy your travels while saving money on fees.
26,830 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
The average social security check is forecast to rise in 2027 as inflation-linked COLA projections point to a sizable...
Public chatter around a high-profile settlement can echo into your finances. This article breaks down the money moves...
Global stablecoins have surged to hundreds of billions in circulation. Analysts warn the next currency crisis could t...
Broadcom is tightening its AI-driven growth narrative with a year-end price target and brisk AI silicon momentum, set...
As AI surges, regulators move faster than hype. Markets put odds of model access curbs at about 27.5% for 2026, reviv...
SpaceX just fell below its IPO price, a moment that sparks questions for every investor. This guide breaks down what ...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
Windermere Real Estate has tapped Diana Wall to lead growth across its independent brokerage network, underscoring a ...
A high-stakes debate is unfolding around SpaceX and its heavy short interest. This article breaks down what it means ...
Broadcom stock has stalled in a sideways move as AI infrastructure spending stays in focus. Analysts weigh a cautious...
Ark Invest’s latest stance on quantum computing raises questions for Rigetti Computing. This guide breaks down the im...